The effects of anti-PD-1 therapy on programmed death-ligand 1 expression and glucose metabolism of normal organs in patients with advanced non-small cell lung cancer
Matthew Severyn(King's College London), Gary Cook(Guy's Hospital), Gitasha Chand(Shanghai First People's Hospital), D.J. Hughes(St Thomas' Hospital), E. Lee(King's College London), Jessica Johnson(University of North Carolina at Chapel Hill), Kathryn Adamson(Guy's and St Thomas' NHS Foundation Trust), Vicky Goh(King's College London), Damion Bailey(Guy's and St Thomas' NHS Foundation Trust)
Cited by 0
Related Papers
De novo mutations in schizophrenia implicate synaptic networks
|Nature|2014|1.7k
Gene expression elucidates functional impact of polygenic risk for schizophrenia
|Nature Neuroscience|2016|1.2k
Regulation of tradeoffs between plant defenses against pathogens with different lifestyles
|Proceedings of the National Academy of Sciences|2007|735
Genomic and epigenetic evidence for oxytocin receptor deficiency in autism
|BMC Medicine|2009|580
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
|Journal of Clinical Oncology|1998|563